Currently, there are 114.19M common shares owned by the public and among those 93.24M shares have been available to trade.
The company’s stock has a 5-day price change of -30.57% and 50.00% over the past three months. ABSI shares are trading 53.44% year to date (YTD), with the 12-month market performance down to -14.10% lower. It has a 12-month low price of $2.45 and touched a high of $6.72 over the same period. ABSI has an average intraday trading volume of 5.05 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -12.91%, 6.36%, and 3.77% respectively.
Institutional ownership of Absci Corp (NASDAQ: ABSI) shares accounts for 63.12% of the company’s 114.19M shares outstanding.
It has a market capitalization of $461.72M and a beta (3y monthly) value of 2.08. The earnings-per-share (ttm) stands at -$0.94. Price movements for the stock have been influenced by the stock’s volatility, which stands at 12.12% over the week and 11.92% over the month.
Analysts forecast that Absci Corp (ABSI) will achieve an EPS of -0.22 for the current quarter, -0.18 for the next quarter and -0.75 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.27 while analysts give the company a high EPS estimate of -0.27. Comparatively, EPS for the current quarter was -0.25 a year ago. Earnings per share for the fiscal year are expected to increase by 28.03%, and 11.77% over the next financial year. EPS should grow at an annualized rate of 19.60% over the next five years, compared to -46.78% over the past 5-year period.
Looking at the support for the ABSI, a number of firms have released research notes about the stock. Needham stated their Buy rating for the stock in a research note on January 22, 2025, with the firm’s price target at $9. Guggenheim coverage for the Absci Corp (ABSI) stock in a research note released on October 02, 2024 offered a Buy rating with a price target of $10. Morgan Stanley was of a view on July 03, 2024 that the stock is Overweight, while Scotiabank gave the stock Sector Outperform rating on March 14, 2024, issuing a price target of $13. KeyBanc Capital Markets on their part issued Overweight rating on December 05, 2023.
